Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?

 
• By Derrick Gingery
  
US-EU cooperation
A lack of awareness of the PSA program for complex generics may be contributing to the lack of interest in it. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics